Resverlogix: Top 25 Undervalued Toronto Stock Exchange Stocks (RVX)
Resverlogix is now ranked among the top 25 undervalued stocks listed on the Toronto Stock Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
- Small, micro and nano group market capitalization (<10B)
Stocks in this category are held primarily for capital appreciation and/or dividends.
The Toronto Stock Exchange (TSX) is the largest exchange in Canada and one of the largest in the world. It is home for “senior” well-established equities.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| IVQ-U | Invesque | 0.12 | 0.44 | 0.32 (267.9%) | 2083 | 6.8 | 0.0 | 0.0 |
| IVQ | Invesque | 0.15 | 0.53 | 0.38 (252.3%) | 20637 | 8.5 | 0.0 | 0.0 |
| VRTS | Vertiqal Studios | 0.01 | 0.04 | 0.03 (181.7%) | 190546 | 9.5 | 0.0 | 0.0 |
| CRWN | Crown Cap Partners | 1.17 | 3.26 | 2.09 (178.5%) | 902 | 6.5 | 0.0 | 0.0 |
| TMD | Titan Medical | 0.05 | 0.13 | 0.08 (177.5%) | 42635 | 5.4 | 0.0 | 0.0 |
| VPH | Valeo Pharma | 0.04 | 0.12 | 0.07 (162.6%) | 41131 | 4.4 | 0.0 | 0.0 |
| MPVD | Mountain Province Diamond | 0.14 | 0.37 | 0.23 (156.4%) | 71528 | 31.1 | 0.0 | 0.6 |
| NVO | Novo Resources | 0.09 | 0.22 | 0.13 (140.8%) | 96848 | 31.9 | 0.0 | 0.0 |
| EXN | Excellon Resources | 0.10 | 0.23 | 0.13 (122.4%) | 237528 | 11.1 | 0.0 | 0.0 |
| CNE | Canacol Energy | 3.40 | 7.36 | 3.96 (116.5%) | 24083 | 116.0 | 15.3 | 7.3 |
| FOOD | Goodfood Market | 0.27 | 0.57 | 0.31 (116.0%) | 33981 | 20.7 | 0.0 | 0.0 |
| AVNT | Avant Brands | 1.00 | 2.15 | 1.15 (115.5%) | 7723 | 9.4 | 0.0 | 0.0 |
| S | Sherritt International | 0.19 | 0.39 | 0.20 (103.9%) | 120481 | 75.5 | 0.0 | 0.0 |
| LCFS | Tidewater Renewables | 2.01 | 4.05 | 2.04 (101.4%) | 30410 | 72.4 | 0.0 | 0.0 |
| CWEB | Charlottes Web Holdings | 0.17 | 0.34 | 0.17 (97.1%) | 33833 | 26.7 | 0.0 | 0.0 |
| CWL | Caldwell Partners Intl | 1.04 | 2.04 | 1.00 (96.0%) | 1951 | 30.7 | 0.0 | 0.0 |
| ACD | Accord Financial | 4.10 | 7.93 | 3.83 (93.5%) | 3291 | 36.2 | 0.0 | 0.0 |
| NCP | Nickel Creek Platinum | 0.79 | 1.52 | 0.73 (91.9%) | 4030 | 4.0 | 0.0 | 0.0 |
| RVX | Resverlogix | 0.07 | 0.12 | 0.06 (89.7%) | 101587 | 17.9 | 0.0 | 0.0 |
| BLDP | Ballard Power Systems | 2.32 | 4.36 | 2.04 (88.0%) | 1481580 | 694.6 | 0.0 | 0.0 |
| LGO | Largo | 2.87 | 5.39 | 2.52 (87.7%) | 40357 | 183.9 | 0.0 | 0.0 |
| QIPT | Quipt Home Medical | 3.78 | 7.06 | 3.28 (86.7%) | 28380 | 161.1 | 0.0 | 0.0 |
| LAAC | Lithium Americas | 5.05 | 9.42 | 4.37 (86.6%) | 481362 | 839.3 | 0.0 | 0.0 |
| PEA | Pieridae Energy | 0.24 | 0.45 | 0.20 (83.7%) | 106485 | 43.2 | 0.0 | 0.0 |
| PIC-A | Premium Income | 4.49 | 8.15 | 3.66 (81.5%) | 60841 | 72.7 | 18.1 | 0.0 |
All data provided as of October 14, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins.
Resverlogix is listed under RVX on the Toronto Stock Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
